levonorgestrel + tenofovir (CerMed)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namelevonorgestrel + tenofovir (CerMed)
Drug Alias NameCerCap HIV
ClassificationSmall molecules
Mechanisms of ActionProgesterone receptor agonistsReverse transcriptase inhibitors
TargetsReverse transcriptaseProgesterone receptor
Therapy Area/IndicationsContraceptionHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAfrica
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesCerMed International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCerMed International Inc
Active IndicationsN/A
Inactive IndicationsContraceptionHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A